NTCOC
VPHM

Northern Trust Company of Connecticut’s VIROPHARMA INC VPHM Stock Holding History

Northern Trust Company of Connecticut’s Portfolio VPHM Stock Details VPHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$751K Sell
15,070
-28,220
-65% -$1.26M ﹤0.01% 1447
2013
Q3 		$1.7M Sell
43,290
-3,220
-7% -$105K 0.01% 1127
2013
Q2 		$1.33M Buy
+46,510
New +$1.23M 0.01% 1189

Other funds holding VPHM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Company of Connecticut's VPHM Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its VIROPHARMA INC (VPHM) stake by 65% in Q4 2013, selling an estimated $1.26M and leaving 15,070 shares worth $751K. The position accounts for ﹤0.01% of the portfolio, ranked #1447.

Northern Trust Company of Connecticut first reported a position in VPHM in Q2 2013 and has held it in 3 quarters since. The position peaked at $1.7M in Q3 2013. 172 funds tracked by Wall St. Rank hold VPHM as of Q4 2013.

  • Northern Trust Company of Connecticut held 15,070 shares of VIROPHARMA INC worth $751K as of Q4 2013.
  • Northern Trust Company of Connecticut sold 28,220 VIROPHARMA INC shares in Q4 2013, an estimated $1.26M.
  • VIROPHARMA INC made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1447 holding.
  • Northern Trust Company of Connecticut first reported a position in VIROPHARMA INC in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's VIROPHARMA INC position peaked at $1.7M in Q3 2013.
  • 172 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.